Regensight

Regensight is the Theranostic Eye Care Health Company. We are pioneering theranostics, a transformative medical approach revolutionizing ophthalmic care through an incision-free technology that seamlessly integrates therapy and real-time molecular imaging diagnostics into a single platform. Our first theranostic platform, C4V CHROMO4VIS, has been clinically validated for the treatment of keratoconus, demonstrating 91% accuracy and 95% precision in halting disease progression through predictive and personalized treatment planning. At Regensight, we are redefining the standard of care in ophthalmology, ushering in a new era of Predictive, Precision, and Personalized Medicine for corneal therapy.